Jpmorgan Chase & Co
3.11xPrice / tangible book
Market cap
$953.44B
Tangible equity
$306.21B
Price / tangible book
3.11x
Price / book
2.63x
Return on equity
15.7%
Return on assets
1.3%
Efficiency ratio
109.9%
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: JPM stock price vs OFIX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OFIX's multiple
Needs OFIX P/E.
Implied fair value · at JPM's multiple
Needs EPS (TTM) is negative.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple premium
Multiple premium
Profitability edge
Asset efficiency edge
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: JPM FY 2025 (ended Dec 31, 2025) · OFIX FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$953.44B
Tangible equity
$306.21B
Price / tangible book
3.11x
Price / book
2.63x
Return on equity
15.7%
Return on assets
1.3%
Efficiency ratio
109.9%
Price / tangible book
Market cap
$378.41M
Tangible equity
$182.34M
Price / tangible book
2.08x
Price / book
0.84x
Return on equity
-20.5%
Return on assets
-10.8%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
JPMORGAN CHASE & CO · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Orthofix Medical Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.18x
0.35x
Net debt / EBITDA
Leverage against operating earnings
—
19.89x
Cash and equivalents
Liquid reserves on the balance sheet
—
$82.03M
Total debt
Interest-bearing obligations outstanding
$64.78B
$157.39M
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Bank of America Corporation
JPM vs BAC
Citigroup Inc.
JPM vs C
Wells Fargo & Company
JPM vs WFC
The Goldman Sachs Group, Inc.
JPM vs GS
Morgan Stanley
JPM vs MS
PNC FINANCIAL SERVICES GROUP, INC.
JPM vs PNC
US BANCORP \DE\
JPM vs USB
STRYKER CORP
JPM vs SYK
ZIMMER BIOMET HOLDINGS, INC.
JPM vs ZBH
Medtronic plc
JPM vs MDT
Johnson & Johnson
JPM vs JNJ
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.